Related Experiment Video
Updated: Jun 10, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Role of substance P in viral myocarditis in mice
Yong Wang1, Miho Shimada, Yawei Xu
1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Kawaracho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Abstract:
Substance P (SP) is widely expressed in the central nervous system and in peripheral tissues such as myocardial nerves. We examined SP in viral myocarditis in mice induced by encephalomyocarditis virus (EMCV). Localization of SP in the hearts was examined immunohistochemically, and concentrations of SP in hearts and sera were measured by enzyme immunoassay. Substance P levels and density of SP-containing cells in murine hearts on day 6 after EMCV inoculation were decreased compared with those in normal controls. There was a negative correlation between SP levels in the hearts and ratio of heart weight to body weight of the mice at 6 days. Circulating SP levels were decreased in mice on day 6 after EMCV inoculation, and further decreased on day 14. Substance P in hearts and sera is decreased in viral myocarditis in mice, suggesting that SP may play a role in the pathogenesis of viral myocarditis, and that interaction of the neuropeptide nervous system and mast-cell immune system is important in the pathogenesis of viral myocarditis.
Insights
Substance P (SP) levels in the heart and blood decrease during viral myocarditis in mice. This suggests SP
Area of Science:
- Neuroimmunology
- Cardiovascular Research
- Virology
Background:
- Substance P (SP) is a neuropeptide found in the central and peripheral nervous systems, including myocardial nerves.
- Viral myocarditis is an inflammatory condition of the heart muscle often caused by viral infections.
Purpose of the Study:
- To investigate the role and levels of Substance P in viral myocarditis induced by encephalomyocarditis virus (EMCV) in a mouse model.
- To explore the relationship between SP levels and cardiac pathology during viral myocarditis.
Main Methods:
- Immunohistochemistry was used to examine SP localization in heart tissue.
- Enzyme immunoassay was employed to quantify SP concentrations in heart and serum samples.
- Viral myocarditis was induced in mice using EMCV.
Main Results:
- SP levels and the density of SP-containing cells in the heart were significantly decreased in EMCV-infected mice compared to controls at day 6 post-infection.
- A negative correlation was observed between cardiac SP levels and the heart weight-to-body weight ratio in infected mice.
- Circulating SP levels were reduced in infected mice at both day 6 and day 14 post-infection.
Conclusions:
- Substance P levels are diminished in both the heart and circulation during viral myocarditis in mice.
- These findings suggest a potential role for SP in the pathogenesis of viral myocarditis.
- The study highlights the importance of the interplay between the neuropeptide nervous system and the mast-cell immune system in viral myocarditis.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
